Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) [Phase 1, Phase 2]
This is a clinical trial update indicating that Substudy 06C is evaluating pembrolizumab in combination with chemotherapy for first-line loc…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
A Semmelweis University study evaluating noninvasive prognostic parameters for esophageal cancer and the esophagogastric junction cancer; cu…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006) [Phase 2]
This clinical trial update reports a Phase 2 study evaluating Cadonilimab in combination with chemoradiotherapy for esophageal cancer (EC-CR…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Phase 1 Study of PF-08046033 in Advanced Solid Tumors [Phase 1]
Pfizer is evaluating PF-08046033 in a Phase 1 trial for adults with advanced solid tumors, including non-small cell lung cancer, esophageal …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction [Phase 2]
This clinical trial update notes a Phase 2 study of adjuvant trastuzumab deruxtecan (Enhertu) in combination with nivolumab for patients who…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors [Phase 1]
Phase 1 clinical trial update showing LY4052031 being studied in advanced or metastatic urothelial cancer and other solid tumors; the study …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. [Phase 3]
Phase 3 clinical trial using 18F-FAPI PET imaging to detect metastatic disease in patients with gastric or esophageal cancer; recruitment is…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
A National Cancer Institute-supported clinical trial is evaluating cell changes in blood and tissue for cancers of the lung, esophagus, and …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors [Phase 1]
A Phase 1 clinical trial update for LY4337713 in participants with FAP-positive solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC [Phase 3]
A Phase 3 clinical trial evaluating concurrent chemoradiotherapy followed by PD-1 inhibitor maintenance for locally advanced esophageal canc…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Patient Preference for Subcutaneous vs. Intravenous Immune Therapy [Phase 2]
Phase 2 clinical trial update on patient preference for subcutaneous versus intravenous immune therapy; the study is currently recruiting ac…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing [Phase 1]
Phase 1 trial update of a vascular-targeted photodynamic therapy (VTP) for esophageal cancer presenting with moderate to severe dysphagia; t…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors [Phase 1]
Phase 1 trial comparing HLX18 to nivolumab (Opdivo) in patients with multiple resected solid tumors, including esophageal/gastric cardia can…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy [Phase 2]
A Phase II single-arm clinical trial is planned to treat locally advanced esophageal cancer after failed neoadjuvant chemoimmunotherapy; the…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for Enzelkitug as a single agent and in combination with a checkpoint inhibitor in adults with locally advance…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers [NA]
This clinical trial update describes a dyadic yoga intervention study to improve physical performance and quality of life in patients with s…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer [Phase 2]
A Phase 2 trial evaluating chemotherapy with or without radiation or surgery for oligometastatic gastric or esophageal cancer; the study is …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Cryotherapy for Locally Advanced Esophageal Cancer [Phase 1]
Phase 1 clinical trial update on cryotherapy for locally advanced esophageal cancer; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial [Phase 2]
Clinical trial update showing a Phase 2 study at MD Anderson Cancer Center comparing proton beam therapy to intensity-modulated radiation th…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
A retrospective clinical study conducted by Nanfang Hospital/Southern Medical University evaluates prognostic factors in esophageal cancer p…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
This entry reports on a clinical trial evaluating outcomes after esophagectomy, with emphasis on minimally invasive techniques and quality o…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Esophageal Cancer Risk Registry
A recruiting clinical trial at the University of Pittsburgh aims to establish an Esophageal Cancer Risk Registry and study links with GERD a…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of LY4101174 in participants with recurrent, advanced or metastatic solid tumors is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the addition of BAY 1895344 to standard chemotherapy (cisplatin or cisplatin…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…